yohimbine and urapidil
yohimbine has been researched along with urapidil in 12 studies
Research
Studies (12)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Aoki, K; Asano, M; Matsuda, T | 1 |
| Gross, G; Hanft, G | 1 |
| Rassier, ME; Shebuski, RJ; Zimmerman, BG | 1 |
| Magometschnigg, D; Schütz, W | 1 |
| Dakshinamurti, K; Lal, KJ | 1 |
| Garnier, P; Goudey-Perriere, F; Perriere, C; Sauviat, MP | 1 |
| Albiero, R; Bernies, M; Bossi, IM; Cassagneau, B; Cugno, M; Di Mario, C; Fajadet, J; Farah, B; Gregorini, L; Grossi, A; Heusch, G; Kozàkovà, M; Marco, J; Palombo, C | 1 |
| Edwards, LP; George, OK; Gonzalez, RR | 1 |
| Frenguelli, BG; Pearson, T | 1 |
| Hu, HT; Li, JH; Ma, QY; Shen, SG; Wang, Z; Zhang, D | 1 |
Trials
1 trial(s) available for yohimbine and urapidil
| Article | Year |
|---|---|
Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Blood Flow Velocity; Blood Pressure; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Stents; Vascular Patency; Yohimbine | 2002 |
Other Studies
11 other study(ies) available for yohimbine and urapidil
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Antagonism of alpha 1-adrenoceptor-mediated vascular contraction by urapidil in isolated arterial strips of spontaneously hypertensive rats.
Topics: Age Factors; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Male; Norepinephrine; Phentolamine; Phenylephrine; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Vasoconstriction; Yohimbine | 1988 |
Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Dioxanes; Heart; In Vitro Techniques; Male; Myocardium; Phenethylamines; Phentolamine; Piperazines; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Tetralones; Yohimbine | 1989 |
Beta 1-adrenoceptor antagonism by urapidil prior to and after the alpha 2-antagonist rauwolscine in anesthetized dogs.
Topics: Animals; Blood Pressure; Dobutamine; Dogs; Drug Administration Schedule; Electric Stimulation; Female; Heart; Heart Rate; Hexamethonium Compounds; Male; Piperazines; Propranolol; Receptors, Adrenergic, beta; Vagotomy; Yohimbine | 1986 |
A clinical approach for the identification of peripheral pre- and post-synaptic alpha-adrenergic receptors.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Male; Norepinephrine; Piperazines; Prazosin; Receptors, Adrenergic, alpha; Synapses; Yohimbine | 1986 |
Hypotensive action of 5-HT receptor agonists in the vitamin B6-deficient hypertensive rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antihypertensive Agents; Blood Pressure; Cerebral Cortex; Clonidine; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Male; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Riboflavin Deficiency; Serotonin; Serotonin Receptor Agonists; Yohimbine | 1993 |
Does crude venom of the stonefish (Synanceia verrucosa) activate beta-adrenoceptors in the frog heart muscle?
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Fish Venoms; Fishes; Heart; Heart Atria; Myocardial Contraction; Myocardium; Piperazines; Propranolol; Rana esculenta; Receptors, Adrenergic, beta; Yohimbine | 1995 |
Moxonidine, an antihypertensive agent, is permissive to alpha1-adrenergic receptor pathway in the rat-tail artery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antihypertensive Agents; Drug Interactions; Imidazoles; Male; Muscle, Smooth, Vascular; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Vasoconstriction; Yohimbine | 2004 |
Adrenoceptor subtype-specific acceleration of the hypoxic depression of excitatory synaptic transmission in area CA1 of the rat hippocampus.
Topics: Adenosine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Drug Interactions; Excitatory Postsynaptic Potentials; Female; Hippocampus; Hypoxia; In Vitro Techniques; Isoproterenol; Male; Neural Inhibition; Neurons; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Synaptic Transmission; Time Factors; Yohimbine | 2004 |
Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Replication; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Pancreatic Neoplasms; Piperazines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Yohimbine | 2008 |